Kai Gerner Email & Phone Number

Portland, Oregon

• Critically evaluated potential investments and joint ventures to address specific needs in the health care industry on a project by project basis• Presented competitive analysis to company executives in the point-of-care diagnostics, in-vitro diagnostics, telemedicine, novel pharmaceutical delivery, and wellness industries• Explored potential strategic partnership synergies and pilot testing for early stage health/tech companies • Worked with external firms to… Show more • Critically evaluated potential investments and joint ventures to address specific needs in the health care industry on a project by project basis• Presented competitive analysis to company executives in the point-of-care diagnostics, in-vitro diagnostics, telemedicine, novel pharmaceutical delivery, and wellness industries• Explored potential strategic partnership synergies and pilot testing for early stage health/tech companies • Worked with external firms to define needs, develop action plan, and implement information technology solution that increased efficiency by over 55% Show less

Portland, Or

• Managed pricing for National Account book of business totaling $200 million in annual premium• Presented recommendation to senior management based on forecast of groups risk and strategicoutlook—resulted in positive membership and revenue growth• Successfully presented private exchange investment analysis which included competitive positioning and long term revenue sufficiency• Led a team of 3 in the creation of new marketing platform--successfully presented to… Show more • Managed pricing for National Account book of business totaling $200 million in annual premium• Presented recommendation to senior management based on forecast of groups risk and strategicoutlook—resulted in positive membership and revenue growth• Successfully presented private exchange investment analysis which included competitive positioning and long term revenue sufficiency• Led a team of 3 in the creation of new marketing platform--successfully presented to executives on stage at company-wide Innovation Conference• Sold new business on Aon Hewitt, Mercer, Towers Watson, and RightOpt private exchanges--while quoting a variety of plans and products Show less

Portland, Oregon

•Developed competitive analysis of the emerging virtual health market, competitors, trends, and barriers to entry for this early-stage company •Showed initiative by creating a work plan, project hypothesis and flexible milestones to track progress and prioritize the companies greatest needs•Data mined and populated target account spreadsheet of nationwide primary care physicians •Presented strategic business expansion plan to company executives that… Show more •Developed competitive analysis of the emerging virtual health market, competitors, trends, and barriers to entry for this early-stage company •Showed initiative by creating a work plan, project hypothesis and flexible milestones to track progress and prioritize the companies greatest needs•Data mined and populated target account spreadsheet of nationwide primary care physicians •Presented strategic business expansion plan to company executives that informed their future actions and decisions that could increase future sales by more than 100% Show less

Eugene, Or

•Enthusiastically communicated in a fast-paced, team environment to dissect Oregon’s capital ecosystem and produce a comprehensive report that was presented to a recognized Advisory Board •Aggregated debt financing amounts available by Economic Development Districts in Oregon •Collaborated with lenders to understand their greatest needs, as well as gaps in available funding with the objective of increasing business development

Corvallis, Oregon

• Conducted pharmaceutical industry competitive analyses to identify current sectors —that helped differentiate the company’s target product portfolio• Created spreadsheets and presentation materials that were used to externally pitch the company’s innovative products and initiatives • Researched and presented to company executives various solutions to current issues with bioavailability and modes of delivery, for specific pharmaceutical ingredients